Free Trial

Acurx Pharmaceuticals (ACXP) Short Interest Ratio & Short Volume

Acurx Pharmaceuticals logo
$4.62 -0.15 (-3.14%)
Closing price 08/29/2025 04:00 PM Eastern
Extended Trading
$4.61 -0.01 (-0.32%)
As of 08/29/2025 07:50 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Acurx Pharmaceuticals Short Interest Data

Acurx Pharmaceuticals (ACXP) has a short interest of 27,000 shares, representing 2.01% of the float (the number of shares available for trading by the public). This marks a -95.77% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.1, indicating that it would take 0.1 days of the average trading volume of 88,686 shares to cover all short positions.

Current Short Interest
27,000 shares
Previous Short Interest
638,200 shares
Change Vs. Previous Month
-95.77%
Dollar Volume Sold Short
$176.04 thousand
Short Interest Ratio
0.1 Days to Cover
Last Record Date
July 31, 2025
Outstanding Shares
1,580,000 shares
Float Size
1,340,000 shares
Short Percent of Float
2.01%
Today's Trading Volume
90,157 shares
Average Trading Volume
88,686 shares
Today's Volume Vs. Average
102%
Short Selling Acurx Pharmaceuticals?
A Guide To High-Short-Interest Stocks

Sign up to receive the latest short interest report for Acurx Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Get Report
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.
Skip Charts & View Short Interest History

ACXP Short Interest Over Time

ACXP Days to Cover Over Time

ACXP Percentage of Float Shorted Over Time

Acurx Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
7/31/202527,000 shares $176.04 thousand -95.8%2.0%0.1 $6.52
7/15/2025638,200 shares $276.72 thousand -3.0%2.5%0.1 $0.43
6/30/2025657,600 shares $335.90 thousand +24.7%3.2%0.1 $0.51
6/15/2025527,300 shares $160.83 thousand +78.4%2.6%0.1 $0.31
5/31/2025295,500 shares $112.97 thousand -23.0%1.5%1.6 $0.38
5/15/2025383,600 shares $143.12 thousand +8.7%1.9%1.5 $0.37
4/30/2025353,000 shares $151.79 thousand -15.7%1.8%1.5 $0.43
4/15/2025418,900 shares $159.18 thousand -11.9%2.2%1.7 $0.38
3/31/2025475,600 shares $185.48 thousand +12.2%2.5%1.3 $0.39
3/15/2025423,800 shares $195.37 thousand -6.4%2.2%1.2 $0.46
2/28/2025452,800 shares $321.26 thousand +112.2%2.7%1.3 $0.71
2/15/2025213,400 shares $158.34 thousand -31.8%1.3%0.6 $0.74
1/31/2025313,100 shares $228.75 thousand -52.2%1.9%1.2 $0.73
1/15/2025655,000 shares $471.53 thousand +41.9%4.0%2.5 $0.72
12/31/2024461,600 shares $375.74 thousand -8.1%2.8%2.2 $0.81
12/15/2024502,100 shares $429.35 thousand +8.2%3.5%4 $0.86
11/30/2024463,900 shares $579.88 thousand +4.6%3.2%4.1 $1.25
11/15/2024443,700 shares $763.16 thousand -6.5%3.1%5.9 $1.72
10/31/2024474,500 shares $892.06 thousand -5.5%3.4%10.1 $1.88
10/15/2024501,900 shares $1.02 million +2.1%3.6%10.2 $2.04
9/30/2024491,700 shares $934.23 thousand +2.8%3.6%7.6 $1.90
9/15/2024478,300 shares $975.73 thousand +5.6%3.5%7.8 $2.04
8/31/2024452,800 shares $996.16 thousand +3.1%3.3%7.7 $2.20
8/15/2024439,400 shares $896.38 thousand -5.4%3.2%8.1 $2.04
7/31/2024464,300 shares $1.00 million -17.3%3.5%7.8 $2.16
7/15/2024561,200 shares $1.34 million -8.6%4.2%9.4 $2.39
6/30/2024614,100 shares $1.38 million -7.1%4.6%10.9 $2.25
6/15/2024661,200 shares $1.61 million -4.0%4.9%10.6 $2.43
5/31/2024688,400 shares $1.73 million +15.6%5.1%9.2 $2.51
5/15/2024595,600 shares $1.34 million -3.2%4.4%7.4 $2.25
4/30/2024615,500 shares $1.38 million +6.3%4.7%7.4 $2.25
4/15/2024579,100 shares $946.83 thousand +71.6%4.8%5.6 $1.64
3/31/2024337,400 shares $826.63 thousand +14.6%2.8%2 $2.45
3/15/2024294,500 shares $801.04 thousand +0.9%2.5%1.7 $2.72
2/29/2024291,900 shares $837.75 thousand -3.2%2.6%1.3 $2.87
2/15/2024301,500 shares $919.58 thousand -12.3%2.7%1.3 $3.05
1/31/2024343,700 shares $1.12 million +41.1%3.0%1.4 $3.27
1/15/2024243,600 shares $1.13 million -18.5%2.1%0.7 $4.63
12/31/2023298,800 shares $1.14 million -32.0%2.6%0.5 $3.83
12/15/2023439,100 shares $1.54 million -21.0%3.9%0.5 $3.50
Why Trump’s “Smart Dollar” could rewrite the rules (Ad)

MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel

Get the three steps to take this month to put yourself on the right side of this $30 trillion money
11/30/2023555,800 shares $1.96 million -14.3%5.0%0.7 $3.52
11/15/2023648,300 shares $2.23 million -31.5%5.8%0.9 $3.44
10/31/2023946,100 shares $5.06 million -9.0%9.0%1.3 $5.35
10/15/20231,040,000 shares $4.51 million +10,197.0%9.9%1.6 $4.34
9/30/202310,100 shares $15.15 thousand +50.8%0.1%0 $1.50
9/15/20236,700 shares $11.86 thousand -51.1%0.1%0.2 $1.77
8/31/202313,700 shares $26.44 thousand +95.7%0.1%0.4 $1.93
8/15/20237,000 shares $11.20 thousand -63.0%0.1%0.2 $1.60
7/31/202318,900 shares $38.37 thousand +42.1%0.2%0.7 $2.03
7/15/202313,300 shares $28.46 thousand +58.3%0.1%0.5 $2.14
6/30/20238,400 shares $22.26 thousand -27.6%0.1%0.3 $2.65
6/15/202311,600 shares $31.90 thousand +39.8%0.1%0.5 $2.75
5/31/20238,300 shares $25.73 thousand -60.9%0.1%0.3 $3.10
5/15/202321,200 shares $71.87 thousand -7.0%0.2%0.7 $3.39
4/30/202322,800 shares $68.17 thousand +4.1%0.3%0.7 $2.99
4/15/202321,900 shares $64.82 thousand -25.5%0.2%0.7 $2.96
3/31/202329,400 shares $101.72 thousand -52.8%0.3%0.9 $3.46
3/15/202362,300 shares $212.44 thousand +150.2%0.7%1.8 $3.41
2/28/202324,900 shares $82.42 thousand -33.8%0.3%0.7 $3.31
2/15/202337,600 shares $131.98 thousand +78.2%0.4%1.2 $3.51
1/31/202321,100 shares $75.96 thousand -7.9%0.2%0.7 $3.60
1/15/202322,900 shares $97.33 thousand -3.4%0.2%0.9 $4.25
12/30/202223,700 shares $94.33 thousand -18.0%0.3%1 $3.98
12/15/202228,900 shares $112.71 thousand +26.8%0.3%1.4 $3.90
11/30/202222,800 shares $72.73 thousand -1.3%0.2%1 $3.19
11/15/202223,100 shares $72.07 thousand +5.5%0.3%1 $3.12
10/31/202221,900 shares $67.45 thousand -27.2%0.2%0.8 $3.08
10/15/202230,100 shares $88.80 thousand -22.2%0.3%1.1 $2.95
9/30/202238,700 shares $116.10 thousand +45.5%0.4%1.5 $3.00
9/15/202226,600 shares $103.74 thousand +10.8%0.3%1 $3.90
8/31/202224,000 shares $83.76 thousand -34.1%0.3%0.9 $3.49
8/15/202236,400 shares $164.16 thousand -13.5%0.4%1.6 $4.51
7/31/202242,100 shares $150.72 thousand +89.6%0.5%2.1 $3.58
7/15/202222,200 shares $80.48 thousand -43.9%N/A1.4 $3.63
6/30/202239,600 shares $150.08 thousand -29.9%N/A2.5 $3.79
6/15/202256,500 shares $213.57 thousand +16.3%N/A3.2 $3.78
5/31/202248,600 shares $130.73 thousand -1.2%N/A2.8 $2.69
5/15/202249,200 shares $133.33 thousand +39.4%N/A2.7 $2.71
4/30/202235,300 shares $131.67 thousand -59.2%N/A2 $3.73
4/15/202286,600 shares $346.40 thousand -22.3%N/A3.3 $4.00
3/31/2022111,400 shares $365.39 thousand +136.5%N/A4 $3.28
3/15/202247,100 shares $175.68 thousand +9.0%N/A1.6 $3.73
2/28/202243,200 shares $157.21 thousand -53.7%N/A1.4 $3.64
2/15/202293,300 shares $376.00 thousand -4.3%N/A2.6 $4.03
1/31/202297,500 shares $405.60 thousand -28.8%N/A2.3 $4.16
1/15/2022137,000 shares $627.46 thousand -16.2%N/A3 $4.58
12/31/2021163,400 shares $706.12 thousand -6.0%N/A3.6 $4.32
12/15/2021173,800 shares $716.06 thousand +52.2%N/A2.9 $4.12
11/30/2021114,200 shares $548.16 thousand -17.1%N/A1.9 $4.80
11/15/2021137,700 shares $684.37 thousand +14.9%N/A2.2 $4.97
Why Trump’s “Smart Dollar” could rewrite the rules (Ad)

MUST SEE: Donald Trump's Radical Overhaul of the U.S. Dollar Congress just approved President Trump's latest plans for the dollar – and they're so bold that one central bank chair says we haven't seen anything like it in almost a century. Our Wall Street insider says it's the start of a once-in-a-lifetime investing opportunity, IF you act now.tc pixel

Get the three steps to take this month to put yourself on the right side of this $30 trillion money
10/29/2021119,800 shares $599 thousand +17.7%N/A1.7 $5.00
10/15/2021101,800 shares $499.84 thousand -4.9%N/A1.2 $4.91
9/30/2021107,000 shares $549.98 thousand +11.2%N/A0.8 $5.14
9/15/202196,200 shares $485.81 thousand +24.9%N/A0.2 $5.05
8/31/202177,000 shares $398.09 thousand -35.9%N/A0.1 $5.17
8/13/2021120,100 shares $576.48 thousand No ChangeN/A0.1 $4.80

ACXP Short Interest - Frequently Asked Questions

What is Acurx Pharmaceuticals' current short interest?

Short interest is the volume of Acurx Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of July 31st, traders have sold 27,000 shares of ACXP short. 2.01% of Acurx Pharmaceuticals' shares are currently sold short. Learn More on Acurx Pharmaceuticals' current short interest.

What is a good short interest percentage for Acurx Pharmaceuticals?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 2.01% of Acurx Pharmaceuticals' floating shares are currently sold short.

Is Acurx Pharmaceuticals' short interest increasing or decreasing?

Acurx Pharmaceuticals saw a drop in short interest during the month of July. As of July 31st, there was short interest totaling 27,000 shares, a drop of 95.8% from the previous total of 638,200 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Acurx Pharmaceuticals' float size?

Acurx Pharmaceuticals currently has issued a total of 1,580,000 shares. Some of Acurx Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Acurx Pharmaceuticals currently has a public float of 1,340,000 shares.

How does Acurx Pharmaceuticals' short interest compare to its competitors?

2.01% of Acurx Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Acurx Pharmaceuticals: Kezar Life Sciences, Inc. (9.46%), Akari Therapeutics PLC (0.15%), CASI Pharmaceuticals Inc. (0.93%), Dare Bioscience, Inc. (2.64%), Trinity Biotech PLC (2.12%), Promis Neurosciences (3.15%), Tenax Therapeutics, Inc. (9.22%), MIRA Pharmaceuticals, Inc. (3.01%), Rallybio Corporation (6.57%), Cadrenal Therapeutics, Inc. (2.39%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($70.87 billion), Invesco QQQ ($30.12 billion), iShares Russell 2000 ETF ($19.85 billion), iShares 20+ Year Treasury Bond ETF ($10.34 billion), Strategy Inc ($8.98 billion), iShares iBoxx $ Investment Grade Corporate Bond ETF ($7.61 billion), SPDR S&P Biotech ETF ($6.81 billion), Invesco S&P 500 Equal Weight ETF ($6.14 billion), Palo Alto Networks, Inc. ($5.97 billion), and Super Micro Computer, Inc. ($5.28 billion). View all of the most shorted stocks.

What does it mean to sell short Acurx Pharmaceuticals stock?

Short selling ACXP is an investing strategy that aims to generate trading profit from Acurx Pharmaceuticals as its price is falling. ACXP shares are trading down $0.15 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Acurx Pharmaceuticals?

A short squeeze for Acurx Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of ACXP, which in turn drives the price of the stock up even further.

How often is Acurx Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including ACXP, twice per month. The most recent reporting period available is July, 31 2025.




This page (NASDAQ:ACXP) was last updated on 9/1/2025 by MarketBeat.com Staff
From Our Partners